Peliosis Hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes

• Published in: Haematologica (Roma) 2007-11, Vol.92 (11), p.e106-e110
• Main Authors: Tsirigotis, P, Sella, T, Shapira, M.Y, Bitan, M, Bloom, A, Kiselgoff, D, Levin, M, Libster, D, Hai, A. Abdul, Gesundheit, B, Or, R, Slavin, S, Resnick, I
• Format: Article
• Language: English
• Subjects: Adult; Androgens - adverse effects; Androgens - therapeutic use; Bone Marrow Diseases - complications; Bone Marrow Diseases - drug therapy; Child; Contraindications; Fanconi Syndrome - complications; Fanconi Syndrome - drug therapy; Female; Hemoglobinuria, Paroxysmal - complications; Hemoglobinuria, Paroxysmal - drug therapy; Humans; Male; Peliosis Hepatis - chemically induced; Peliosis Hepatis - etiology; Steroids - adverse effects; Steroids - therapeutic use
• ISSN: 0390-6078; 1592-8721
• DOI: 10.3324/haematol.11343

Department of Bone Marrow Transplantation and Cancer Immunotherapy; Department of Radiology, Department of Haematology; Hadassah, Hebrew University Medical Center, Jerusalem, Israel Correspondence: Igor B. Resnick, Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel. Tel: [phone]; Fax: [phone]. E-mail: gashka{at}hadassah.org.il Androgens widely used in the treatment of bone marrow failure syndromes can in rare cases cause hepatic peliosis, a pathological entity characterized by multiple blood-filled cavities in the liver parenchyma. Bone marrow failure syndromes per se are associated with a low coagulation status, which is further magnified by bone marrow transplantation for aplastic anaemia due to deep thrombocytopenia. Both these conditions can cause bleeding; their combination is especially dangerous. We describe two cases of aplastic anaemia due to paroxysmal nocturnal hemoglobinuria and Fanconi syndrome, in which patients developed peliosis hepatis after prolonged treatment with androgens. One patient developed severe subcapsular bleeding, successfully treated with catheterization of the right hepatic artery and embolization of the bleeding site. The second patient bridged over deep post-transplant aplasia with high frequency platelet transfusions, and demonstrated an uncomplicated post-BMT course. We suggest avoiding or interrupting treatment with androgens in patients preparing for BMT. Key words: Peliosis Hepatis, Androgens, Bone marrow transplantation, Fanconi Anaemia, Paroxysmal nocturnal Hemoglobinuria.